Heart Disease


To evaluate a new mitral valve replacement in patients who moderate-severe or severe mitral regurgitation at a high surgical risk.

Trial overview


Heart failure

Eligibility criteria

To be considered for the study you must meet the following criteria:

  • Aged 18 years or older
  • Moderate-severe or severe mitral regurgitation
  • Unable to undertake open heart surgery

Study details

Your participation in this study would be for approximately 5 years.

You will need to attend a pre-screening period which consists of a CT scan, 6 min walk test, a blood test and ultrasound of your heart. If eligible, you will need to undergo a procedure to have a valve inserted and stay in hospital for up to 2-3 days. You will then be followed up post procedure, 7 days after discharge, at 1, 3 ,6, 12 months and then annually up to 5 years. During these visits you will be asked about your health and medications and have a physical examination, blood test, echocardiogram and ECG.

You will be reimbursed for travel and study related expenses.

Further information

For more information on this clinical trial here.


Murdoch (Cardiology)

Wesley Hospital Auchenflower (Cardiology Consulting)

Mater Brisbane (Cardiology)

Milton (Cardiology)

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.